CARBIDOPA-LEVODOPA
·
Carbidopa inhibits
peripheral levodopa enzyme (decarboxylase) so that the levodopa can cross the
blood-brain barrier efficiently.
·
Levodopa resolves
dopamine deficiency by being converted to dopamine after crossing blood-brain
barrier.
·
Ratio: 1 part
carbidopa to 10 parts levodopa
·
Improves all the
symptoms of Parkinsonism, especially bradykinesia and rigidity.
·
Contraindication:
Patients with severe cardiac, renal or psychiatric health problems
·
Brand names:
Sinemet®, Atamet®
Side effects:
·
Nausea and
vomiting
|
·
Dyskinesia
|
·
Orthostatic
hypotension
|
·
Cardiac
arrhythmias
|
·
Psychoses (e.g
paranoia, hallucination) and abnormal behavior (increased libido)
|
·
Dark urine and
perspiration
|
MAO-B INHIBITORS
(also see antidepressant drugs)
·
Inhibits the
enzyme (MAOB) that breaks down dopamine in the basal ganglia; enables
dopamine to remain active for longer periods of time
·
It is used during
the early disease to slow progression. It allows less levodopa to be used to
achieve effects similar to larger doses of levodopa hence prolonging the onset
of end-of-dose deterioration.
Example:
selegiline/deprenyl (Eldepryl®, Zelapar®, Emsam®
transdermal)
Side effects:
·
Dizziness
|
·
Stomach pain
& heart burn
|
·
Dry mouth
|
·
Diarrhea
|
·
Nausea &
vomiting
|
·
Dysphagia
|
AMANTADINE
·
An antiviral
medication that has a stimulating or enhancing effect in the release of
remaining dopamine in the basal ganglia which in turn could delay the necessity
of levodopa therapy.
·
Common brand
names: Symadine®, Symmetrel®
Side effects:
·
Orthostatic
hypotension
|
·
Urinary
retention
|
·
Confusion
|
·
Constipation
|
·
Purple mottling
|
·
Insomnia
|
DOPAMINE AGONIST
·
Directly stimulate
dopamine receptors in basal ganglia
·
Enhances the
effect of Sinemet therapy. It is used when levodopa responsiveness is
diminishing
Example:
Generic
names
|
Brand
names
|
bromcriptine
|
Parlodel®
|
pergolide mesylate
|
Permaz®
|
pramipexole
|
Mirapex®
|
ropinirole
|
Requip®
|
Side effects:
·
Nausea
|
·
Palpitation
|
·
Hypotension
|
·
Edema
|
·
Chest pain
|
·
Hallucinations
and confusion
|
ANTICHOLINERGICS
·
Inhibits excessive
acetylcholine influence caused by dopamine deficiency
·
N.b single daily
doses are best given at bed time.
·
Indication: Useful
in control of tremor. Minimal effect on rigidity and bradykinesia
·
Contraindication: patient with glaucoma, myasthenia gravis, GI obstruction, achalasia,
prostatic hypertrophy
Example:
Generic
names
|
Brand
names
|
benztropine
|
Cogentin®
|
trihexyphenidyl
|
Artane®
|
biperiden
|
Akineton®
|
ethoproprazine
|
Parsidol®
|
orphenadrine
|
Disipal®, Norlfex®, Banflex®
|
procyclidine
|
Kemadrin®
|
Side effects:
·
Dry mouth
|
·
Blurred vision
|
·
Urinary
retention
|
·
Tachycardia
|
·
Constipation
|
·
Restlessness and
confusion
|
CATHECOL-O-METHYLTRANSFERASE
INHIBITORS (COMT)
·
Adjunct to Sinemet
therapy to treat patients with the signs and symptoms of end-of-dose
deterioration"wearing-off".
·
Usually used in
combination with Sinemet®
·
Contraindications: patients taking MAO-1 inhibitors
Example: entacapone (Comtan®), tolcapone (Tasmar®)
Side effects: intensify the adverse effects of levodopa (e.g restlessness, loss of balance control,
dysarthria, dysphagia)
BETA-BLOCKERS (see antihypertensive
drugs)
·
Used to reduce the
severity of tremors
·
Example:
propanolol
Nursing Consideration:
ü Check for fluctuations in symptoms related to dosing
(end-of-dose deterioration, on-off phenomenon, dyskinesia). These are common
with disease progression and long-term use of levodopa (e.g 2-3 years of use).
ü Check for signs of orthostaic hypotension: weakness, dizziness or syncope.
ü Avoid high protein diet. Spread protein intake
thoughout the day. High caloric diet is
also recommended.
ü Advise patient not to abruptly discontinue Sinemet
therapy. Rebound parkinsonism may occur.
ü Inform the patient about the effects of medication on
secretions (e.g urine or perspiration may
be dark)
ü Advise the patient to avoid foods rich in Vitamin B6
(pyridoxine) and such as cereals and beans. It increases the potency of dopa
decarboxylase
ü Be vigilant for signs of hypertensive crisis especially
for patients taking levodopa combined with MAO inhibitor antidepressant